92640 ⎘
Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS
#2ANTIDEPRESSANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING DEPRESSION AND OTHER DISORDERS
#3USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#4LIPIDS FOR NUCLEIC ACID DELIVERY
#5AMINOKETONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#6R-KETAMINE SALTS AND METHODS OF USE THEREOF
#7ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
#8HYDROXYNORKETAMINE COMPOUNDS AND METHODS OF USE THEREOF
#9HYDROXYNORKETAMINE ANALOGUES, COMPOSITIONS COMPRISING SAME AND METHODS OF USE THEREOF
#10CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE
#11NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS
#12SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME
#13ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
#14Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#15CRYSTALLINE FORMS OF HYDROXYNORKETAMINE
#16Small molecules active against gram-negative bacteria
#17Compositions and methods for the treatment of cancer
#18Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#19Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders
#20COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION
#21AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
#22Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
#23(S)-CSA Salt Of S-Ketamine, (R)-CSA Salt Of S-Ketamine And Processes For The Preparation Of S-Ketamine
#24COMPOSITIONS AND METHODS FOR TREATING CANCER AND INFLAMMATORY DISEASES
#25USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#26Crystalline forms of hydroxynorketamine
#27Processes for the preparation of heterocyclic scaffolds from alpha enaminones
#28Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#29Ketamine Derivatives
#30Anti-fibrotic pyridinones
#31Small molecules active against gram-negative bacteria
#32Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
#33Compositions and methods for treating liver cancer
#34Mu opioid receptor modulators
#35(S)-CSA salt of S-ketamine, (R)-CSA salt of S-ketamine and processes for the preparation of S-ketamine
#36SHIP1 modulators and methods related thereto
#37Cyclic vinylogous amides as bromodomain inhibitors
#38USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#39Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#40Ketamine derivatives
#41Anti-fibrotic pyridinones
#42Bulky ligands and metal compounds comprising bulky ligands
#43Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#44Assay for methoxetamine
#45Small molecule inhibitors of Dusp6 and uses therefor
#46Multifunctional primary amine, process for its preparation, and use thereof
#47(S)-CSA SALT OF S-KETAMINE, (R)-CSA SALT OF S-KETAMINE AND PROCESSES FOR THE PREPARATION OF S-KETAMINE
#481,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#49SHIP1 modulators and methods related thereto
#50Cyclic vinylogous amides as bromodomain inhibitors
#51SHIP1 MODULATORS AND METHODS RELATED THERETO
#52Multifunctional radical quenchers
#53Substituted tropolone derivatives and methods of use
#543-KETO-N-PROPARGYL-1-AMINOINDAN
#55N-cycloalkyl-N-[(cycloalkenylphenyl)methylene]-(thio)carboxamide derivatives
#56Multifunctional primary amine, process for its preparation, and use thereof
#57Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#58Polyureas made from aminocrotonates
#591,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#60Genes for biosynthesis of tetracycline compounds and uses thereof
#61Method for synthesizing substituted aminocyclohexanone compounds
#62Small molecule inhibitors of Dusp6 and uses therefor
#63FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#64USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS
#653,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
#66Methods for Preparing S1P Receptor Agonists and Antagonists
#673-KETO-N-PROPARGYL-1-AMINOINDAN
#681-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
#69AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY
#70Genes for biosynthesis of tetracycline compounds and uses thereof
#713,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
#72Polyureas made from aminocrotonates and enaminones
#73Substituted hydroxyethylamine aspartyl protease inhibitors
#74Merocyanine derivatives for cosmetic use
#75Two step process for preparing substituted anisidines
#76Mono, di and tri cyclic compounds useful for lowering IgE concentrations
#77Squaric Acid Derivatives as Protein Kinase Inhibitors
#78Substituted cyclohexanones
#79Squaric Acid Derivatives
#80Merocyanine derivatives for cosmetic use
#81Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases
#82Compounds and methods for carbazole synthesis
#83Cyclic compounds
#843,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
#85Mono di & tri cyclic compounds useful for lowering IgE concentrations
#86Pro-fragrance and pro-flavorant compositions
#87Michael addition product and Schiff's base aromachemicals
#88Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
#89Pharmaceutically useful compounds
#90IL-8 receptor antagonists
#91Substituted hydroxyethylamine aspartyl protease inhibitors
#92Narcotic-NSAID ion pairs